382 related articles for article (PubMed ID: 9629466)
1. New substituted 9-alkylpurines as adenosine receptor ligands.
Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
[TBL] [Abstract][Full Text] [Related]
2. 9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.
Klotz KN; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):629-34. PubMed ID: 12734636
[TBL] [Abstract][Full Text] [Related]
3. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
[TBL] [Abstract][Full Text] [Related]
4. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
[TBL] [Abstract][Full Text] [Related]
5. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
Kim YC; de Zwart M; Chang L; Moro S; von Frijtag Drabbe Künzel JK; Melman N; IJzerman AP; Jacobson KA
J Med Chem; 1998 Jul; 41(15):2835-45. PubMed ID: 9667972
[TBL] [Abstract][Full Text] [Related]
7. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA
J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463
[TBL] [Abstract][Full Text] [Related]
9. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
Siddiqi SM; Jacobson KA; Esker JL; Olah ME; Ji XD; Melman N; Tiwari KN; Secrist JA; Schneller SW; Cristalli G
J Med Chem; 1995 Mar; 38(7):1174-88. PubMed ID: 7707320
[TBL] [Abstract][Full Text] [Related]
10. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.
Areias F; Correia C; Rocha A; Teixeira S; Castro M; Brea J; Hu H; Carlsson J; Loza MI; Proença MF; Carvalho MA
Molecules; 2024 May; 29(11):. PubMed ID: 38893418
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
[TBL] [Abstract][Full Text] [Related]
13. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
[TBL] [Abstract][Full Text] [Related]
14. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
[TBL] [Abstract][Full Text] [Related]
15. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
[TBL] [Abstract][Full Text] [Related]
16. A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
Ferrarini PL; Mori C; Manera C; Martinelli A; Mori F; Saccomanni G; Barili PL; Betti L; Giannaccini G; Trincavelli L; Lucacchini A
J Med Chem; 2000 Jul; 43(15):2814-23. PubMed ID: 10956189
[TBL] [Abstract][Full Text] [Related]
17. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
Karton Y; Jiang JL; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jun; 39(12):2293-301. PubMed ID: 8691424
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
Jacobson KA; Siddiqi SM; Olah ME; Ji XD; Melman N; Bellamkonda K; Meshulam Y; Stiles GL; Kim HO
J Med Chem; 1995 May; 38(10):1720-35. PubMed ID: 7752196
[TBL] [Abstract][Full Text] [Related]
20. Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.
Mundell SJ; Kelly E
Biochem Pharmacol; 1998 Mar; 55(5):595-603. PubMed ID: 9515570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
